focus -WSS

focus

author：knowledge 2025-10-02 11:09:15 - browse：8

Paul Friedrichs, who will lead the new White House office on pandemic preparedness, speaks at the Pentagon — White House coverage from STAT — Paul Friedrichs, who will lead the new White House office on pandemic preparedness, speaks at the Pentagon. AP Photo/Alex Brandon

WASHINGTON – The White House on Friday launched its pandemic preparedness office, half a year after Congress instructed the administration to set up a new arm in the wake of the coronavirus pandemic.

The Office of Pandemic Preparedness and Response Policy is a now-permanent installment in Washington and will first be led by retired Major General Paul Friedrichs, a longtime biosecurity official. It comes roughly two months after the Covid-19 public health emergency ended and weeks after Covid-19 response coordinator Ashish Jha stepped down, reflecting an overall wind-down of the administration’s coronavirus efforts.

The creation of a pandemic preparedness office was one of the last major bipartisan pushes for Sen. Richard Burr (R-N.C.) before retiring. He and Sen. Patty Murray (D-Wash.) pressed congressional leadership to include the office’s establishment and other pandemic provisions in a spending package passed last December.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Ancient Greek ideas underpin modern concepts of pregnancy

WSS

In utero gene editing: an explainer

6 phony surgeries that take placebo to the extreme

A solution to the after

PBM reform efforts get punted in Congress

Why palliative psychiatry is worth discussing

Alabama frozen embryo ruling has major implications for IVF clinics

focus

focus

entertainment

How to save PrEP access — and even expand it

Microsoft's Peter Lee: Generative AI could help doctors be more human

Medical leaders decry Supreme Court decision on affirmative action

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: BridgeBio, Akero, and human embryo models

Wildfire smoke exposes gaps in outdoor worker protections

Fetal cell organoids grown from amniotic fluid, study finds

At least 13 dead in Texas as scorching temps continue

Ed Silverman on new gene therapies, biosimilars, coffee, and more

hotspot

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Stem cell biologist probes earliest stages of human development

Families look for replacement for GSK asthma drug Flovent

First over

IVF doctors demand details after CooperSurgical lawsuit

$1 billion proposal to grow Boston, Massachusetts biotech

hotspot

leisure time

entertainment

entertainment